UAB Clinical Trials Offer Opportunities for Participation in Groundbreaking Research

The University of Alabama at Birmingham (UAB) is at the forefront of medical research, offering numerous clinical trials that aim to improve health outcomes across a variety of conditions. Here's a closer look at some of the studies currently seeking participants:

• CT-388-104 Study: Focused on individuals aged 18-75 with a BMI of 25 or above and diagnosed with type 2 diabetes, this study tests the safety and effectiveness of a selective GLP-1/GIP investigational drug. Participants may receive the drug or placebo, along with medical care and lifestyle counseling.

• Nearsightedness in Children Study: Aimed at children aged 8-12 who need glasses or contact lenses, this research explores the potential of a new contact lens to treat nearsightedness. Participants will receive free contact lenses and compensation.

• Vision Rehabilitation Research: Healthy adults aged 50-59 are needed to help lay the foundation for using a new device, the Bioness Integrated Therapy System (BITS), in treating visual impairments. The study involves short surveys and functional tests, with participants receiving a $25 gift card.

• DISCOVERY Study: Targeting children aged 9-14 at risk for type 2 diabetes, this study involves in-person and phone visits, lab tests, questionnaires, and physical exams. Families across the US are encouraged to participate to help make a difference for all children.

• Schizophrenia Study: Adults aged 35-65 with schizophrenia are needed to help researchers understand how the condition affects individuals as they age. The study includes clinical interviews, cognitive tests, MRI scans, and compensation up to $310.

• Urinary Leakage Study: Individuals aged 65 and older experiencing urine leakage may qualify for this study assessing the effectiveness of hip exercises on pelvic floor muscle strength. Compensation of $100 is provided.

• HIV Vaccine Study: Adults aged 18-60 living with HIV and with a suppressed viral load are sought for a study testing an experimental HIV vaccine. Compensation and transportation services are available.

• TRANSCEND-T2D-2 Study: Adults with type 2 diabetes are needed to test the efficacy and safety of an investigational medicine compared to existing treatments. The study involves taking medications and monitoring blood glucose and weight.

• PRECISION-BP Study: This research investigates the effects of Sacubitril/Valsartan or Valsartan on the body's 24-hour rhythm of natriuretic peptides, related to heart health. Eligible participants must be obese with high blood pressure and no history of heart or kidney problems. Compensation is $575 for completing study visits.

For more information on these studies and how to participate, contact the provided email addresses or phone numbers.